These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 21766137)

  • 1. MicroRNAs dysregulated in breast cancer preferentially target key oncogenic pathways.
    Lim WK; Micklem G
    Mol Biosyst; 2011 Sep; 7(9):2571-6. PubMed ID: 21766137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-21 as a key regulator of oncogenic processes.
    Selcuklu SD; Donoghue MT; Spillane C
    Biochem Soc Trans; 2009 Aug; 37(Pt 4):918-25. PubMed ID: 19614619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of targets and functions coregulated by microRNAs.
    Chen SJ; Chen HC
    Methods Mol Biol; 2011; 676():225-41. PubMed ID: 20931401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs in breast cancer pathogenesis.
    Götte M
    Minerva Ginecol; 2010 Dec; 62(6):559-71. PubMed ID: 21079577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of ErbB receptor signalling in cancer cells by microRNA.
    Barker A; Giles KM; Epis MR; Zhang PM; Kalinowski F; Leedman PJ
    Curr Opin Pharmacol; 2010 Dec; 10(6):655-61. PubMed ID: 20864407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
    Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR
    Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Let-7 family miRNAs regulate estrogen receptor alpha signaling in estrogen receptor positive breast cancer.
    Zhao Y; Deng C; Wang J; Xiao J; Gatalica Z; Recker RR; Xiao GG
    Breast Cancer Res Treat; 2011 May; 127(1):69-80. PubMed ID: 20535543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational methods for analysis of cellular functions and pathways collectively targeted by differentially expressed microRNA.
    Gusev Y
    Methods; 2008 Jan; 44(1):61-72. PubMed ID: 18158134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22.
    Patel JB; Appaiah HN; Burnett RM; Bhat-Nakshatri P; Wang G; Mehta R; Badve S; Thomson MJ; Hammond S; Steeg P; Liu Y; Nakshatri H
    Oncogene; 2011 Mar; 30(11):1290-301. PubMed ID: 21057539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA expression profiles in human colorectal cancers with liver metastases.
    Lin M; Chen W; Huang J; Gao H; Ye Y; Song Z; Shen X
    Oncol Rep; 2011 Mar; 25(3):739-47. PubMed ID: 21174058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation.
    White NM; Bao TT; Grigull J; Youssef YM; Girgis A; Diamandis M; Fatoohi E; Metias M; Honey RJ; Stewart R; Pace KT; Bjarnason GA; Yousef GM
    J Urol; 2011 Sep; 186(3):1077-83. PubMed ID: 21784468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs associated with tumour migration, invasion and angiogenic properties in A549 and SK-Lu1 human lung adenocarcinoma cells.
    Ho CS; Yap SH; Phuah NH; In LL; Hasima N
    Lung Cancer; 2014 Feb; 83(2):154-62. PubMed ID: 24360396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA involvement in the pathogenesis and management of breast cancer.
    Khoshnaw SM; Green AR; Powe DG; Ellis IO
    J Clin Pathol; 2009 May; 62(5):422-8. PubMed ID: 19398594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA expression profiling and bioinformatics analysis of dysregulated microRNAs in vinorelbine-resistant breast cancer cells.
    Zhong S; Ma T; Zhang X; Lv M; Chen L; Tang J; Zhao J
    Gene; 2015 Feb; 556(2):113-8. PubMed ID: 25445394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of altered MicroRNA expression patterns in synovial sarcoma.
    Hisaoka M; Matsuyama A; Nagao Y; Luan L; Kuroda T; Akiyama H; Kondo S; Hashimoto H
    Genes Chromosomes Cancer; 2011 Mar; 50(3):137-45. PubMed ID: 21213367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of miRNA-gene expression-genomic profiles reveals complex mechanisms of microRNA deregulation in osteosarcoma.
    Maire G; Martin JW; Yoshimoto M; Chilton-MacNeill S; Zielenska M; Squire JA
    Cancer Genet; 2011 Mar; 204(3):138-46. PubMed ID: 21504713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential microRNA therapies targeting Ras, NFkappaB and p53 signaling.
    Kasinski AL; Slack FJ
    Curr Opin Mol Ther; 2010 Apr; 12(2):147-57. PubMed ID: 20373258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prioritizing breast cancer subtype related miRNAs using miRNA-mRNA dysregulated relationships extracted from their dual expression profiling.
    Hua L; Zhou P; Li L; Liu H; Yang Z
    J Theor Biol; 2013 Aug; 331():1-11. PubMed ID: 23619378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Differential expression profiles of microRNAs between breast cancer cells and mammary epithelial cells].
    Zhang H; Su SB; Zhou QM; Lu YY
    Ai Zheng; 2009 May; 28(5):493-9. PubMed ID: 19624877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The miR-17-92 cluster is over expressed in and has an oncogenic effect on renal cell carcinoma.
    Chow TF; Mankaruos M; Scorilas A; Youssef Y; Girgis A; Mossad S; Metias S; Rofael Y; Honey RJ; Stewart R; Pace KT; Yousef GM
    J Urol; 2010 Feb; 183(2):743-51. PubMed ID: 20022054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.